novel strategy for the targeted analysis of protein and peptide metabolites
In many biological applications such as epitope discovery or drug metabolism studies, the detection of naturally processed exogenous proteins (e.g. vaccines or peptide therapeutics) and their metabolites is frequently complicated by the presence of a complex endogenous mixture of closely related or...
Saved in:
Published in | Proteomics (Weinheim) Vol. 11; no. 2; pp. 183 - 192 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley-VCH Verlag
01.01.2011
WILEY-VCH Verlag WILEY‐VCH Verlag Wiley-VCH Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In many biological applications such as epitope discovery or drug metabolism studies, the detection of naturally processed exogenous proteins (e.g. vaccines or peptide therapeutics) and their metabolites is frequently complicated by the presence of a complex endogenous mixture of closely related or even identical compounds. We describe a method that incorporates stable isotope labelling of the protein of interest, allowing the selective screening of the intact molecule and all metabolites using a modified precursor ion scan. This method involves monitoring the low-molecular-weight fragment ions produced during MS/MS that distinguish isotopically labelled peptides from related endogenous compounds. All isotopically labelled peptides can be selected using this method. The technique makes no assumptions about the processed or post-translational state of the peptide, and hence can selectively screen out modified peptides that would otherwise be missed by single reaction monitoring approaches. This method does not replace single reaction monitoring or regular precursor scanning techniques; instead, it is a method that can be used when the assumptions required for the former two techniques cannot be predicted. The potential for this technique to be used in metabolism and pharmacokinetic experiments is discussed with specific examples looking at the metabolism of α-synuclein in serum and the brain. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/pmic.201000474 ArticleID:PMIC201000474 ark:/67375/WNG-8T085LG0-1 Australian Research Council - No. LP0669856 National Institutes of Health - No. GM057428-06; No. NS036592-09 istex:00C52B071B8C91BE7B0CE04B333BA6BA5CB82AF3 National Health and Medical Research Council of Australia Senior Research Fellow National Health and Medical Research Council of Australia - No. 508929 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1615-9853 1615-9861 1615-9861 |
DOI: | 10.1002/pmic.201000474 |